| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/04/2012 | CN102526154A Method for preparing antitumor medicine burdock root extractive |
| 07/04/2012 | CN102526150A Method for preparing total elecampane sesquiterpene lactone extract |
| 07/04/2012 | CN102526146A Medicament composition containing ginsenoside and cantharidin and application of medicament composition |
| 07/04/2012 | CN102526142A Glaucescent fissistigma root granules and preparation method thereof |
| 07/04/2012 | CN102526133A Pine needle extracts and preparation method thereof |
| 07/04/2012 | CN102526129A Method for preparing Poria cocos granules by replacing part of auxiliary materials with ultrafine powder |
| 07/04/2012 | CN102526127A Flash type extraction method for active constituents in cordyceps militaris |
| 07/04/2012 | CN102526115A Medicament for treating and preventing immune diseases and cancers |
| 07/04/2012 | CN102526111A Slow-release microsphere containing venenum bufonis lipoclastic substances as well as preparation method and application thereof |
| 07/04/2012 | CN102526081A Medicinal composition capable of inhibiting proliferation of tumor cells |
| 07/04/2012 | CN102526077A Application of phenylacetyl fluorobenzene salicylamide compound for preparing anti-leukemia drugs |
| 07/04/2012 | CN102526073A Application of mogrol H9 for preparing antitumor drugs |
| 07/04/2012 | CN102526055A Application of cyclohexanediamine hypocrelline B in photodynamic anti-tumor medicaments |
| 07/04/2012 | CN102526053A Composition containing gallocatechin epicatechol gallate and vincristine and capable of inhibiting proliferation of tumor cells |
| 07/04/2012 | CN102526046A Antitumor medicinal composition containing epigallocatechin gallate (EGCG) and sorafenib and application thereof |
| 07/04/2012 | CN102526041A Application of picrasma quassioides alkaloid serving as STAT3 (Signal Transducer and Activator of Transcription 3) signal specificity inhibitor |
| 07/04/2012 | CN102526038A Temozolomide brain-targeting pharmaceutical composition and application thereof |
| 07/04/2012 | CN102526033A Composition prepared from epigallocatechin gallate and mitomycin C and used for suppressing tumor cell proliferation |
| 07/04/2012 | CN102526024A Anticancer pharmaceutical composition |
| 07/04/2012 | CN102526022A Application of epigallocatechin-3-gallate in preparation of antitumor drug |
| 07/04/2012 | CN102526020A Application of oridonin in preparing activator of tumor-suppressor protein FBW7 |
| 07/04/2012 | CN102526018A Application of carbamic acid alkannin ester to preparation of pyruvate kinase inhibitor |
| 07/04/2012 | CN102526013A Medicament composition and application thereof |
| 07/04/2012 | CN102526011A Application of retinoic acid in preparing medicines for curing breast cancer |
| 07/04/2012 | CN102525996A Capsules containing fludarabine phosphate and preparation method for capsules |
| 07/04/2012 | CN102525981A Propranolol hydrochloride tablets and preparation method thereof |
| 07/04/2012 | CN102525964A Gemcitabine hydrochloride lyophilized powder injection |
| 07/04/2012 | CN102525958A Oxaliplatin- and hydroxypropyl-beta-cyclodextrin-containing injection composition and preparation method thereof |
| 07/04/2012 | CN102525957A Preparation method of Oxaliplatin for injection |
| 07/04/2012 | CN102525955A Preparation method of pemetrexed disodium for injection |
| 07/04/2012 | CN102525954A Lyophilized emulsion preparation for injection of levo-gossypol and acetate of levo-gossypol |
| 07/04/2012 | CN102525941A Composite drug-loading sustained release microsphere system entrapped with quantum dots and preparation method of composite drug-loading sustained release microsphere system |
| 07/04/2012 | CN102525936A Compound epirubicin hydrochloride polylactic-co-glycolic acid (PLGA) nanoparticles and preparation method thereof |
| 07/04/2012 | CN102525933A Poly-L-lactic acid and polyethyleneglycol block copolymer (PLLA-PEG) supported 5-fluorouracil nanoparticles and preparation method thereof |
| 07/04/2012 | CN102525931A Pentaplatin liposome preparation and preparation method thereof |
| 07/04/2012 | CN102525929A Wogonin liposome preparation modified with glycyrrhetinic acid and preparation method thereof |
| 07/04/2012 | CN102525928A Cis-platinum long-cycle liposome and preparation method thereof |
| 07/04/2012 | CN102525927A Octreotide acetate preparation and preparation method thereof |
| 07/04/2012 | CN102525914A Injection sustained-release preparation of LHRH (luteinizing hormone releasing hormone) antagonist substance and preparation thereof |
| 07/04/2012 | CN102525891A Adenosine cyclophosphate injection and preparation method thereof |
| 07/04/2012 | CN102525882A Nanocomposite temperature-sensitive gel and preparation method and application thereof |
| 07/04/2012 | CN102240298B Pharmaceutical composition for resisting tumors |
| 07/04/2012 | CN102210659B Bifidobacterium microcapsule and preparing method thereof |
| 07/04/2012 | CN102198210B Quality control method of xiaojiean preparation |
| 07/04/2012 | CN102168069B Cell strain capable of inducing and realizing dual-stabilization of P53 expression and construction method and application thereof |
| 07/04/2012 | CN102161649B Polyphenol type derivatives extracted from mulberry leaves and preparation method and applications thereof |
| 07/04/2012 | CN102153650B Anti-EGFR (epidemic growth factor receptor) humanized antibody L2-H3 and coding gene and application thereof |
| 07/04/2012 | CN102153649B Anti-epidemic growth factor receptor (EGFR) humanized antibody L1-H3 and coded gene and application thereof |
| 07/04/2012 | CN102153648B EGFR (epidermal growth factor receptor)-inhibiting humanized antibody L4-H3 and encoding genes and application thereof |
| 07/04/2012 | CN102153647B Anti-EGFR (epidemic growth factor receptor) humanized antibody L3-H3 and coding gene and application thereof |
| 07/04/2012 | CN102151325B Traditional Chinese medicine for treating breast diseases |
| 07/04/2012 | CN102127087B Quinazoline derivatives |
| 07/04/2012 | CN102125638B Traditional Chinese medicine for treating gastric cancers and preparation method thereof |
| 07/04/2012 | CN102121023B Mutant human plasminogen kringle5, preparation method and application thereof |
| 07/04/2012 | CN102114198B Traditional Chinese medicine for treating lymph cancer |
| 07/04/2012 | CN102114039B Method for processing Tibetan medicine calcite |
| 07/04/2012 | CN102100836B Medicinal composition for treating tumors, preparation method thereof and application thereof |
| 07/04/2012 | CN102091110B Chinese patent medicine capsule for treating lung cancer |
| 07/04/2012 | CN102091031B Preparation method of arylhydroxamic acid organotin anti-tumor compound injection |
| 07/04/2012 | CN102078517B Traditional Chinese medicine for treating tumor |
| 07/04/2012 | CN102078352B Composition for treating cancers |
| 07/04/2012 | CN102030812B Timosaponin A-III serving as medicinal active ingredient with angiogenesis resistance |
| 07/04/2012 | CN102008685B Chinese medicinal powder for treating liver cancer, lung cancer and pancreatic cancer |
| 07/04/2012 | CN101991862B Cyclodextrin-polyethyleneimine-mediated supramolecular delivery system and preparation method |
| 07/04/2012 | CN101991770B Medicament for treating malignant tumors |
| 07/04/2012 | CN101991606B Preparation method of solid water-soluble lead-removed propolis |
| 07/04/2012 | CN101967125B Hsp90 inhibitor Xbj-B16-1 and preparation method and application thereof |
| 07/04/2012 | CN101961371B Method for extracting and separating ginsenoside, flavone and polysaccharide from sweet gynostemma pentaphylla |
| 07/04/2012 | CN101955480B Pyrazolo [3,4-b] quinoline compound and preparation method thereof |
| 07/04/2012 | CN101955465B 5-fluoropyrimidine-4(3H)-ketone compound and preparation method and application thereof |
| 07/04/2012 | CN101953776B Non-spherical drug-loaded particles and controlled release preparation of lactyl polymer and preparation methods thereof |
| 07/04/2012 | CN101948508B Tumor-resistance CTL (Cytotoxic T Lymphocyte) epitope peptide derived from PIWIL2 and application thereof |
| 07/04/2012 | CN101948472B Novel staurosporine analogue and preparation method and applications thereof |
| 07/04/2012 | CN101940797B Cladded nuclide labeled protein microsphere, preparation method and applications thereof |
| 07/04/2012 | CN101928293B Bisindole alkaloid compound, medicine composition thereof and preparation method and application of medicine composition |
| 07/04/2012 | CN101919991B Drug composition for treating cervical cancer and preparation method thereof |
| 07/04/2012 | CN101914118B Trehalose derivant and preparation method and application thereof |
| 07/04/2012 | CN101912426B Method for preparing ginkgo exocarp anti-tumor effective part and preparation thereof |
| 07/04/2012 | CN101899096B Blood group A epitope mimic peptide and application thereof |
| 07/04/2012 | CN101891704B N-(2-(2-amine)oxyethylthiobenzothiazole-6-)-2-formamide derivative as well as preparation method and applciaiton thereof |
| 07/04/2012 | CN101880281B Thiophane nucleoside analogues and preparation method and application thereof |
| 07/04/2012 | CN101875695B Antibody, and coding gene and application thereof |
| 07/04/2012 | CN101851199B Substituted piperazine N-ethyl sulfonamide derivative and preparation and application thereof |
| 07/04/2012 | CN101849978B Method for extracting polyphenol active ingredient in geranium wilfordii through high-efficiency enzyme induction |
| 07/04/2012 | CN101830961B Ursolic acid ester derivatives, preparation method thereof and application thereof |
| 07/04/2012 | CN101829318B Use of IL-28 and IL-29 to treat cancer and autoimmune disorders |
| 07/04/2012 | CN101824434B Antigen presenting cell, preparation method thereof and application thereof |
| 07/04/2012 | CN101810662B Elephantopus scaber linn extractive, preparation method and applications thereof |
| 07/04/2012 | CN101805355B Thienopyridone derivative, preparation method and uses thereof |
| 07/04/2012 | CN101804209B PEDF (Pigment Epithelial Derived Factor) gene PLGA nano compound as well as preparation method and use thereof |
| 07/04/2012 | CN101798349B Anti-uPAR humanized antibody and coding gene thereof |
| 07/04/2012 | CN101797367B Traditional Chinese medicinal capsule for treating hysteromyoma and preparation method thereof |
| 07/04/2012 | CN101792484B Anthracycline derivative of polypeptide containing tyrosine-isoleucine-glycine-serine-arginine |
| 07/04/2012 | CN101791379B Traditional Chinese medicine compound oral preparation for preventing and treating tumor diseases |
| 07/04/2012 | CN101781355B Method for preparing limonin, composition and application thereof |
| 07/04/2012 | CN101780092B Compounds and methods for delivery of prostacyclin analogs |
| 07/04/2012 | CN101775073B Drug for inhibiting proliferation of tumor cells and application thereof |
| 07/04/2012 | CN101768130B Derivatives containing aminomethyl-5-membered aromatic heterocycle-4-carboxylic acid, preparation method, drug combination and application thereof |
| 07/04/2012 | CN101759804B Anti-human thyroglobulin monoclonal antibody and application thereof |
| 07/04/2012 | CN101757598B Traditional Chinese medicine composition for treating advanced malignant liver tumor symptoms and preparation method thereof |